Chinese biotechnology firm 3SBio Inc. said it agreed to be bought by Decade Sunshine Ltd. for about $340 million, Reuters reported. The offer of $15.40 per American Depositary Shares is at a premium of about 12 percent to the ADS’s Thursday close of $13.79.
(Reuters) – Chinese biotechnology firm 3SBio Inc said it agreed to be bought by Decade Sunshine Ltd for about $340 million.
